(Q54561813)
Statements
Rituximab-augmented myeloablation for first-line autologous stem cell transplantation for mantle cell lymphoma: effects on molecular response and clinical outcome. (English)
1 reference
Peter Dreger
1 reference
Michael Rieger
1 reference
Bärbel Seyfarth
1 reference
Manfred Hensel
1 reference
Michael Kneba
1 reference
Anthony D Ho
1 reference
Norbert Schmitz
1 reference
Christiane Pott
1 reference
1 January 2007
1 reference
1 reference
92
1 reference
42-49
1 reference
1
1 reference
Identifiers
1 reference